405 related articles for article (PubMed ID: 22832924)
1. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.
Rieg T; Gerasimova M; Murray F; Masuda T; Tang T; Rose M; Drucker DJ; Vallon V
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F963-71. PubMed ID: 22832924
[TBL] [Abstract][Full Text] [Related]
2. Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.
Katagiri D; Hamasaki Y; Doi K; Okamoto K; Negishi K; Nangaku M; Noiri E
J Am Soc Nephrol; 2013 Dec; 24(12):2034-43. PubMed ID: 24092928
[TBL] [Abstract][Full Text] [Related]
3. Diuretic and Natriuretic Effects of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin: The Contribution of Glucagon-like Peptide-1.
Moroi M; Kubota T
J Cardiovasc Pharmacol; 2015 Aug; 66(2):159-64. PubMed ID: 25853991
[TBL] [Abstract][Full Text] [Related]
4. Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4.
Vallon V; Docherty NG
Exp Physiol; 2014 Sep; 99(9):1140-5. PubMed ID: 25085841
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.
Crajoinas RO; Oricchio FT; Pessoa TD; Pacheco BP; Lessa LM; Malnic G; Girardi AC
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F355-63. PubMed ID: 21593184
[TBL] [Abstract][Full Text] [Related]
6. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors.
Morales J
Postgrad Med; 2011 Nov; 123(6):189-201. PubMed ID: 22104467
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury.
Higashijima Y; Tanaka T; Yamaguchi J; Tanaka S; Nangaku M
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F878-87. PubMed ID: 25656369
[TBL] [Abstract][Full Text] [Related]
8. The physiological role of glucagon-like peptide-1 in the regulation of renal function.
Farah LX; Valentini V; Pessoa TD; Malnic G; McDonough AA; Girardi AC
Am J Physiol Renal Physiol; 2016 Jan; 310(2):F123-7. PubMed ID: 26447224
[TBL] [Abstract][Full Text] [Related]
9. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
10. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
12. Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways.
Shah Z; Pineda C; Kampfrath T; Maiseyeu A; Ying Z; Racoma I; Deiuliis J; Xu X; Sun Q; Moffatt-Bruce S; Villamena F; Rajagopalan S
Vascul Pharmacol; 2011; 55(1-3):2-9. PubMed ID: 21397040
[TBL] [Abstract][Full Text] [Related]
13. Role of Renal Sympathetic Nerves in GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist Exendin-4-Mediated Diuresis and Natriuresis in Diet-Induced Obese Rats.
Liu X; Patel KP; Zheng H
J Am Heart Assoc; 2021 Nov; 10(21):e022542. PubMed ID: 34713714
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
Schlatter P; Beglinger C; Drewe J; Gutmann H
Regul Pept; 2007 Jun; 141(1-3):120-8. PubMed ID: 17276524
[TBL] [Abstract][Full Text] [Related]
16. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
17. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
18. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ
Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat.
Thomson SC; Kashkouli A; Singh P
Am J Physiol Renal Physiol; 2013 Jan; 304(2):F137-44. PubMed ID: 23019232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
